LBPH: Longboard Pharmaceuticals Inc Stock Price

Longboard Pharmaceuticals (LBPH) is competing with biotech behemoths for priority in patenting gene therapy methods. The business model relies on outsourcing trials to external laboratories under strict management control, with the metric standing at 60.01. This price chart illustrates the asset's dynamics. High barriers to entry are driven by colossal R&D costs and stringent FDA oversight regarding the development of drugs for rare pathologies.

Quote Chart: Longboard (LBPH) for 07/04/2022 - 12/07/2024

Longboard Pharma (LBPH) - metric breakdowns and financial figures

- stock value and consensus price forecast:

Price Chart Longboard Pharmaceuticals, Inc.|LBPH - Price Target Chart

- market capitalization information:

Market Capitalization Longboard|LBPH - Total Company Value

- book capitalization information:

Net Assets per Single Share Longboard Pharmaceuticals|LBPH - Net Asset Value|Market Capitalization to Book Value Ratio longboardpharma.com|LBPH - Aggregate Asset Value

- debt obligations and liquidity statistics:

- company profitability and valuation multiples indicators:

LBPH - Company Net Income|Expected Profit Longboard Pharmaceuticals|LBPH - Price to Earnings Ratio|Future Price to Earnings longboardpharma.com|LBPH - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Longboard Pharmaceuticals, Inc.|LBPH - Operating profit before amortization|Net earnings per share (EPS TTM) Longboard Pharmaceuticals|LBPH - Net earnings per share for the trailing year|Quarterly EPS earnings growth longboardpharma.com|LBPH - Earnings per share growth in current year|Net earnings per share growth forecast for next year Longboard Pharmaceuticals

- sales and revenue indicators:

LBPH - Company Total Revenue|Projected Sales Volume longboardpharma.com|LBPH - P/S Multiple|Price-to-Projected Revenue Ratio Longboard Pharmaceuticals

Analysis of all company metrics:longboardpharma.com LBPH

Signature product of Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals is investing significant resources into the development of neurobiological drugs for the treatment of rare CNS pathologies. The price history reflects the market value of a single share, converting the innovator's total capitalization into a specific cash equivalent, which allows investors to assess the fundamental value of the business through the lens of current demand for its scientific potential.

Analysis of competing companies